መነሻ › ኖን-ስማል ሴል የሳንባ ካንሰር › ዲስትሪክት ኦፍ ኮሎምቢያ › Washington
በWashington፣ DC ለኖን-ስማል ሴል የሳንባ ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች
ለኖን-ስማል ሴል የሳንባ ካንሰር የሚደረጉ 55 ጥናቶች በWashington እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- እና 1 ተጨማሪ
Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- National Institutes of Health Clinical Center, Bethesda · 7 ማይል ርቀት
A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Local Institution - 0183, Washington D.C.
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
A Study of PHN-012 in Patients With Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- PHN-012-001 Site, Washington D.C.
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Johns Hopkins Office of Capital Region Research - Sibley Memorial Hospital, Washington D.C.
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- National Institutes of Health Clinical Center, Bethesda · 7 ማይል ርቀት
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Maryland Oncology Hematology, P.A., Silver Spring · 7 ማይል ርቀት
- Maryland Oncology Hematology, P.A., Bethesda · 7 ማይል ርቀት
- Maryland Oncology Hematology, P.A, Largo · 11 ማይል ርቀት
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- National Institutes of Health Clinical Center, Bethesda · 7 ማይል ርቀት
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Research Site, Silver Spring · 7 ማይል ርቀት
- Research Site, Bethesda · 7 ማይል ርቀት
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Maryland Oncology Hematology, P.A., Silver Spring · 7 ማይል ርቀት
- Maryland Oncology Hematology, P.A., Bethesda · 7 ማይል ርቀት
- Maryland Oncology Hematology, P.A., Largo · 11 ማይል ርቀት
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- MedStar Georgetown University Hospital, Washington D.C.
- Washington DC VA Medical Center, Washington D.C.
- Maryland Oncology Hematology P A, Silver Spring · 7 ማይል ርቀት
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Georgetown University, Washington D.C.
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Washington DC Veterans Affairs Medical Center, Washington D.C.
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
ተሳታዮችን በመፈለግ ላይደረጃ 2
- MedStar Georgetown University Hospital, Washington D.C.
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Sibley Memorial Hospital, Washington D.C.
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
ተሳታዮችን በመፈለግ ላይደረጃ 1
- National Institutes of Health Clinical Center, Bethesda · 7 ማይል ርቀት
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- MedStar Georgetown-MedStar Georgetown Transplant Institute University Hospital (MGUH), Washington D.C.
- MEDSTAR Washington Hospital Center (MedStar Health Research Institute), Washington D.C.
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Georgetown University Medical Center, Washington D.C.
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Research Site, Bethesda · 7 ማይል ርቀት
- Research Site, Bethesda · 7 ማይል ርቀት
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
ተሳታዮችን በመፈለግ ላይደረጃ 3
- George Washington University Cancer Center, Washington D.C.
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Georgetown University Lombardi Cancer Center, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- Local Institution - 007-5476, Washington D.C.
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- MedStar Georgetown University Hospital (Lombardi Comprehensive Cancer Center), Washington D.C.
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Sibley Memorial Hospital, Washington D.C.
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Walter Reed National Military Medical Center, Bethesda · 7 ማይል ርቀት
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Washington Hospital Center ( Site 0037), Washington D.C.
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- National Institutes of Health Clinical Center, Bethesda · 7 ማይል ርቀት
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Research Site, Bethesda · 7 ማይል ርቀት
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- MedStar Georgetown University Hospital, Washington D.C.
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Sibley Memorial Hospital, Washington D.C.
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Sibley Memorial Hospital, Washington D.C.
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- National Institutes of Health, Bethesda · 7 ማይል ርቀት
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Georgetown University - Lombardi Comprehensive Cancer Center, Washington D.C.
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Georgetown University Medical Center, Washington D.C.
Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node or Other High Risk Features
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington D.C.
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Georgetown University, Washington D.C.
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Maryland Oncology Hematology, Calverton · 12 ማይል ርቀት
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Georgetown University Medical Center, Washington D.C.
Gilteritinib for the Treatment of ALK NSCLC
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Georgetown University, Washington D.C.
Study of XB010 in Subjects With Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Georgetown University Medical Center, Washington D.C.
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- Kaiser Permanente - Largo Medical Center, Largo · 11 ማይል ርቀት
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 2
- USA11-0, Bethesda · 7 ማይል ርቀት
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Georgetown University Medical Cener (GUMC), Washington D.C.
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Research Site, Washington D.C.
- Research Site, Bethesda · 7 ማይል ርቀት
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- Kaiser Permanente - Largo Medical Center, Largo · 11 ማይል ርቀት
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- Kaiser Permanente - Largo Medical Center, Largo · 11 ማይል ርቀት
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Sibley Memorial Hospital, Washington D.C.
Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
- Medstar Washington Hospital Center, Washington D.C.
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- National Cancer Institute, Bethesda · 7 ማይል ርቀት
Repositioning Immunotherapy in VetArans With Lung Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- VA Central Office, Washington, DC, Washington D.C.
GEMINI-NSCLC: NSCLC Biomarker Study
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- The Center for Cancer and Blood Disorder, Bethesda · 7 ማይል ርቀት
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- The George Washington University Cancer Center (site 212), Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Massive Bio SYNERGY-AI site, Silver Spring · 7 ማይል ርቀት
- Massive Bio SYNERGY-AI site, Bethesda · 7 ማይል ርቀት
FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
በሌሎች ከተሞች ለኖን-ስማል ሴል የሳንባ ካንሰር የሚደረጉ ጥናቶች
- Houston, TX145 ጥናቶች
- New York City, NY121 ጥናቶች
- Arlington, VA104 ጥናቶች
- Nashville, TN97 ጥናቶች
- Boston, MA90 ጥናቶች
- Los Angeles, CA87 ጥናቶች
- St. Louis, MO73 ጥናቶች
- Chicago, IL61 ጥናቶች
- Baltimore, MD60 ጥናቶች
- San Antonio, TX59 ጥናቶች
- Columbus, OH57 ጥናቶች
- Seattle, WA53 ጥናቶች
በWashington ውስጥ ያሉ ሌሎች ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)58 ጥናቶች
- የጡንቻ ካንሰር46 ጥናቶች
- Metastatic Cancer43 ጥናቶች
- የሳንባ ካንሰር41 ጥናቶች
- የፕሮስቴት ካንሰር38 ጥናቶች
- ከባድ ሰውነት33 ጥናቶች
- የኮሎሬክታል ካንሰር29 ጥናቶች
- የልብና የደም ዝውውር ሕመም28 ጥናቶች
- የሽንት ፊኛ ካንሰር26 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ24 ጥናቶች
- የእንቁላል ካንሰር23 ጥናቶች
- ሊምፎማ23 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።